相关产品推荐更多 >

HLA-E Antibody, anti-human, FITC, REAfinity™, 100 tests in 200 µL
询价
CD33 Antibody, anti-human, FITC, REAlease®, 30 tests in 60 µL
询价
CD223 Antibody, anti-mouse, PE, REAfinity™, 30 µg in 200 µL
询价
CD301 (CLEC10A) Antibody, anti-human, PE, REAfinity™, 100 tests in 200 µL
询价
CD43 Antibody, anti-mouse, PE-Vio® 770, REAfinity™, 150 µg in 1 mL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
PI3K p85 α
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,4-8℃
- 克隆性:
REAL589
- 标记物:
APC
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi biotec
- 宿主:
cell line
- 应用范围:
MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry
- 抗体英文名:
PI3K p85 α Antibody, anti-human, REAdye_lease™
- 抗体名:
PI3K p85 α Antibody, anti-human, REAdye_lease™
- 规格:
200 µL
Detection of PI3K p85 α+ cellsClone REAL589 is an antibody fragment derived from the full PI3K p85 alpha antibody molecule. It displays no binding to Fc receptors. The recombinantly engineered antibody fragments are multimerized to form the REAdye_lease Complex to bind markers with high avidity. | Clone REAL589 recognizes the human Phosphoinositide 3-kinase (PI3K), also known as phosphatidylinositol 3-kinase which belongs to the family of related intracellular signal transducer enzymes. PI3Ks are involved in cellular functions such as cell growth, proliferation, differentiation, motility, survival and intracellular trafficking. Mutations in the gene promote the development of diseases such as allergies, heart diseases, inflammatory processes or cancer. The superfamily of PI3 Kinases consists of several enzymes, which are structurally closely related. | For removal of REAdye_lease fluorochromes for optional relabeling with different fluorochrome-conjugated REAdye_lease antibodies use the REAlease Support Kit (130-120-675).
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Thorpe, L. M. et al. (2015) PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. Nat. Rev. Cancer 15 (1): 7–24. | Kaneda, M. M. et al. (2016) PI3Kγ is a molecular switch that controls immune suppression. Nature 539 (7629): 437–442. | Rodgers, S. J. et al. (2017) Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases. Biosci. Rep. 37 (1): –BSR2016043.
技术资料暂无技术资料 索取技术资料
文献支持
PI3K p85 α Antibody, anti-human, APC, REAdye_lease™, 200 µL
询价





